HALCION Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Halcion, and what generic alternatives are available?
Halcion is a drug marketed by Pfizer and is included in one NDA.
The generic ingredient in HALCION is triazolam. There are six drug master file entries for this compound. Ten suppliers are listed for this compound. Additional details are available on the triazolam profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Halcion
A generic version of HALCION was approved as triazolam by NOVAST LABS on October 20th, 2020.
Summary for HALCION
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Finished Product Suppliers / Packagers: | 3 |
Raw Ingredient (Bulk) Api Vendors: | 38 |
Clinical Trials: | 3 |
Patent Applications: | 5,073 |
Formulation / Manufacturing: | see details |
Drug Prices: | Drug price information for HALCION |
What excipients (inactive ingredients) are in HALCION? | HALCION excipients list |
DailyMed Link: | HALCION at DailyMed |
Recent Clinical Trials for HALCION
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Boston Medical Center | Phase 4 |
Akili Interactive Labs, Inc. | N/A |
Investigación Farmacológica y Biofarmacéutica | Phase 1 |
Pharmacology for HALCION
Drug Class | Benzodiazepine |
Anatomical Therapeutic Chemical (ATC) Classes for HALCION
US Patents and Regulatory Information for HALCION
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Pfizer | HALCION | triazolam | TABLET;ORAL | 017892-003 | Apr 26, 1985 | AB | RX | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
Pfizer | HALCION | triazolam | TABLET;ORAL | 017892-001 | Nov 15, 1982 | AB | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
Pfizer | HALCION | triazolam | TABLET;ORAL | 017892-002 | Nov 15, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for HALCION
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Pfizer | HALCION | triazolam | TABLET;ORAL | 017892-001 | Nov 15, 1982 | ⤷ Try a Trial | ⤷ Try a Trial |
Pfizer | HALCION | triazolam | TABLET;ORAL | 017892-001 | Nov 15, 1982 | ⤷ Try a Trial | ⤷ Try a Trial |
Pfizer | HALCION | triazolam | TABLET;ORAL | 017892-002 | Nov 15, 1982 | ⤷ Try a Trial | ⤷ Try a Trial |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for HALCION
See the table below for patents covering HALCION around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
Belgium | 779988 | ⤷ Try a Trial | |
African Intellectual Property Organization (OAPI) | 3446 | ⤷ Try a Trial | |
Philippines | 9329 | 6-PHENYL-1-SUBSTITUTED-4H-S-TRIAZOLO(4,3-A)-BENZODIAZEPINES | ⤷ Try a Trial |
>Country | >Patent Number | >Title | >Estimated Expiration |